Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catalyst Pharmaceuticals

25.87
+0.51002.01%
Post-market: 26.050.1799+0.70%19:59 EDT
Volume:1.20M
Turnover:31.18M
Market Cap:3.16B
PE:16.49
High:26.09
Open:25.65
Low:25.57
Close:25.36
Loading ...

Catalyst Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for William T. Andrews, Chief Medical Officer

Reuters
·
9 hours ago

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
05 Jun

Catalyst Pharmaceuticals CEO Daly buys 70,000 common shares

TIPRANKS
·
04 Jun

Richard J. Daly, President and CEO of Catalyst Pharmaceuticals, Reports Disposal of Common Shares

Reuters
·
04 Jun

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, Md, Facp as Chief Medical Officer

THOMSON REUTERS
·
02 Jun

Press Release: Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

Dow Jones
·
02 Jun

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 May

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
29 May

Catalyst Pharmaceuticals Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
28 May

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 May

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
22 May

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
20 May

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 May

Gary Ingenito, Chief Med. & Reg. Officer, Reports Disposal of Common Shares of Catalyst Pharmaceuticals Inc

Reuters
·
16 May

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
15 May

Catalyst Pharmaceuticals Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
13 May

Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
10 May

Catalyst Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
08 May

Catalyst Pharmaceuticals Q1 Adj. EPS $0.68 Beats $0.53 Estimate, Sales $141.42M Beat $130.86M Estimate

Benzinga
·
08 May